Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression
- PMID: 32183820
- PMCID: PMC7076940
- DOI: 10.1186/s12958-020-00576-1
Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression
Abstract
Background: A limited number of publications have assessed the prevalence of hypertension (HTN) in polycystic ovary syndrome (PCOS) patients with inconclusive results. Since in general populations the occurrence of hypertension is related to age per se, we investigated the prevalence (P) / relative risk (RR) of HTN in pooled patients with PCOS, vs control population among reproductive age women with PCOS, compared to menopause/aging patients.
Methods: PubMed, Scopus, ScienceDirect, web of science, and Google scholar were systematically searched for retrieving observational studies published from inception to April 2019 investigating the HTN in patients with PCOS. The primary outcome of interest was pooled P and RR of HTN in reproductive and menopausal/aging women with PCOS compared to control population.
Results: The pooled prevalence of HTN in reproductive and menopausal/aging women with PCOS was higher than in the control population [(Pooled P: 0.15, 95% CI: 0.12-0.18 vs. Pooled P: 0.09, 95% CI: 0.08-0.10) and (Pooled P: 0.49, 95% CI: 0.28-0.70 vs. Pooled P: 0.40, 95% CI: 0.22-0.57), respectively]. Compared to the control population, pooled relative risk (RR) of HTN patients was increased only in reproductive age PCOS (1.70-fold, 95% CI: 1.43-2.07) but not in menopausal/aging patients who had PCOS during their reproductive years. The same results were obtained for subgroups of population-based studies. Meta-regression analysis of population-based studies showed that the RR of HTN in reproductive age PCOS patients was 1.76-fold than menopausal/aging PCOS patients (P = 0.262).
Conclusion: This meta-analysis confirms a greater risk of HTN in PCOS patients but demonstrates that this risk is increased only in reproductive age women with PCOS, indicating that after menopause, having a history of PCOS may not be as an important predisposing factor for developing HTN.
Keywords: Hypertension; Meta-analysis; Polycystic ovary syndrome; Relative risk.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.Gynecol Endocrinol. 2020 Jan;36(1):12-23. doi: 10.1080/09513590.2019.1650337. Epub 2019 Aug 6. Gynecol Endocrinol. 2020. PMID: 31385729
-
Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.Elife. 2023 Aug 3;12:e85338. doi: 10.7554/eLife.85338. Elife. 2023. PMID: 37534878 Free PMC article.
-
Polycystic ovary syndrome is an independent risk factor for hypertensive disorders of pregnancy: A systematic review, meta-analysis, and meta-regression.Endocrine. 2021 Dec;74(3):518-529. doi: 10.1007/s12020-021-02886-9. Epub 2021 Oct 16. Endocrine. 2021. PMID: 34655376
-
The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis.Clin Endocrinol (Oxf). 2018 Feb;88(2):169-184. doi: 10.1111/cen.13477. Epub 2017 Oct 16. Clin Endocrinol (Oxf). 2018. PMID: 28930378
-
Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis.Gynecol Endocrinol. 2021 May;37(5):392-405. doi: 10.1080/09513590.2020.1859474. Epub 2020 Dec 23. Gynecol Endocrinol. 2021. PMID: 33355023
Cited by
-
Impaired fecundity as a marker of health and survival: a Danish twin cohort study.Hum Reprod. 2021 Jul 19;36(8):2309-2320. doi: 10.1093/humrep/deab077. Hum Reprod. 2021. PMID: 34009293 Free PMC article.
-
Hypertension in Women.Front Cardiovasc Med. 2022 Jun 3;9:905504. doi: 10.3389/fcvm.2022.905504. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35722103 Free PMC article. Review.
-
Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia-A New Insight on Syndrome Pathogenesis.Int J Environ Res Public Health. 2020 Dec 11;17(24):9291. doi: 10.3390/ijerph17249291. Int J Environ Res Public Health. 2020. PMID: 33322590 Free PMC article.
-
Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding.Clin Med Insights Endocrinol Diabetes. 2024 Oct 28;17:11795514241296777. doi: 10.1177/11795514241296777. eCollection 2024. Clin Med Insights Endocrinol Diabetes. 2024. PMID: 39494232 Free PMC article.
-
Cardiovascular Properties of the Androgen-Induced PCOS Model in Rats: The Role of Oxidative Stress.Oxid Med Cell Longev. 2021 Aug 31;2021:8862878. doi: 10.1155/2021/8862878. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34512871 Free PMC article.
References
-
- Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219. - PubMed
-
- Calderon-Margalit R, Siscovick D, Merkin SS, Wang E, Daviglus ML, Schreiner PJ, et al. Prospective Association of Polycystic Ovary Syndrome with coronary artery calcification and carotid-intima-media thickness significance: the coronary artery risk development in young adults Women’s study. Arterioscler Thromb Vasc Biol. 2014;34(12):2688–2694. - PubMed
-
- Dahlgren E, Janson P, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand. 1992;71(8):599–604. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous